Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4187-4190

  Braun, J M ^a   Ko, H L ^a   Schierholz, J M ^a   Beuth, J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antimetastatic activity; BALB c mice; Immunomodulation; Standardized mistletoe extract

Indexed keywords

VISCUM ALBUM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; IMMUNOMODULATION; LEUKOCYTE COUNT; LIVER METASTASIS; LUNG METASTASIS; LYMPHOSARCOMA; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; STATISTICAL ANALYSIS; THYMOCYTE; TUMOR VOLUME; VISCUM ALBUM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; DISEASE MODELS, ANIMAL; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; LYMPHOMA, DIFFUSE; MICE; MICE, INBRED BALB C; MISTLETOE; PLANT PREPARATIONS; PLANT PROTEINS; SARCOMA, EXPERIMENTAL; TOXINS, BIOLOGICAL;

EID: 0036875696     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wagner H: Viscum album - die Mistel. Deutsche Apotheker Zeitung 124: 1429-1432, 1984.
2. Stein GM, Edlund U, Pfueller U, Buessing A and Schietzel M: Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes, and granulocytes in vitro. Anticancer Res 19: 3907-3914, 1999.
3. Scheffler A, Musielski H and Scheer R: Synergismus zwischen Lektinen und Vesikeln von Viscum album L. Dtsch Zschrft Onkologie 27: 72-78, 1995.
4. Lenartz D, Dott U, Menzel J, Schierholz JM and Beuth J: Survival of patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res 20: 2073-2076, 2000.
5. Ribereau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P and Anton R: Mistletoe lectins I, II, and III induce the production of cytokines by cultured human monocytes. Cancer Lett 109: 33-38, 1996.
6. Beuth J, Stoffel B, Samtleben R, Staak O, Ko HL, Pulverer G and Wagner H: Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c-mice. Phytomedicine 2: 269-273, 1996.
7. Beuth J: Clinical relevance of immunoactive mistletoe lectin-1. Anti-Cancer Drugs 8: 53-55, 1997.
8. Buessing A: Biologische Wirkungen der Mistel. Zschrft Onkol 31: 35-43, 1999.
9. Buessing A, Rosenberger A, Stumpf C and Schietzel M: Entwicklung lymphozytärer Subpopulationen bei Tumopatienten nach subkutaner Applikation von Mistelextrakten. Forschende Komplementarmedizin 6: 196-204, 1999.
10. + cells with "memory" phenotype CCD-62 LEO) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L. Cell Death Diff 5: 231-240, 1998.
11. Kubasova T, Pfueller U, Koeteles GJ, Csollak M and Eifler R: Comparative studies in some cellular and immunological effects of mistletoe isolectins in vitro. In: van Driessche E (Ed.) Lectins: Biology, Biochemistry, Clinical Biochemistry, Vol. 11, Textop Hellerup: 240-244, 1996.
12. Beuth J, Schierholz JM and Mayer G: Thymosin α1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice. Cancer Lett 159: 9-13, 2000.
13. Beuth J and Moss RW: Wissenschaftlich-begründete komplementäre Therapiemaßnahmen in der Onkologie. Z Onkol/J of Oncol 32: 45-49, 2000.
14. Kuttan G, Menon LG, Antony S and Kuttan R: Anticarcinogenic and antimetastatic activity of Iscador. Anti-Cancer Drugs 8: 15-16, 1997.
15. Ribereau-Gayon G, Jung ML, Frantz M and Anton R: Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anti-Cancer Drugs 8: 3-8, 1997.
16. Buessing A, Stein GM, Stumpf C and Schietzel M: Release of interleukin-6 in cultured B-chronic lymphatic leukaemia cells is associated with both activation and cell death via apoptosis. Anticancer Res 19: 3953-3960, 1999.
17. Buessing A: Induction of apoptosis by the mistletoe lectins. A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1: 25-32, 1996.
18. Braun JM, Gemmell CG, Beuth J, Ko HL and Pulverer G: Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin. Int J Bacteriology 283: 90-94, 1995.
19. Heiny BM and Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces β-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 14: 1339-1342, 1994.
20. Beuth J, Ko HL, Gabius H-J and Pulverer G: Influence of treatment with the immunomodulatory effective dose of the β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental models. In Vivo 5: 29-32, 1991.
21. Stein GM and Berg PA: Mistletoe extract-induced effects on immunomopetent cells: in vitro studies. Anti-Cancer Drugs 8: 39-42, 1997.
22. Staak O, Stoffel B, Wagner H, Pulverer G and Beuth J: In vitro Zytotoxizität der Viscum album Agglutinine I und II. J Oncol 30: 29-33, 1998.
23. Buessing A: Biological and pharmacological properties of Viscum album L. From tissue flask to men. In: Buessing A (Ed.) Mistletoe. The Genus Viscum, Harwood Academic Publishers, Singapore: 123-182, 2000.